SCHEMBL3686563

SCHEMBL3686563

CC(C)(C)N(CC1CN(Cc2ccccc2)CCO1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 20/20 0.55
DRD2 P14416 4/20 0.52
DRD3 P35462 4/20 0.52
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3020210 1.00 DRD4 (0.55) DRD4DRD2DRD3CYP1A2CYP3A4
SCHEMBL3093945 0.88 DRD4 (0.54) DRD4DRD2DRD3CYP1A2CYP3A4
SCHEMBL7924048 0.80 DRD4 (0.66) DRD4DRD2DRD3CYP1A2CYP3A4
SCHEMBL4397749 0.80 ACHE (0.53)
SCHEMBL3524495 0.80 ACHE (0.53)
SCHEMBL10513580 0.79 DRD4 (0.61) DRD4DRD2DRD3CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL10510482 0.79 DRD4 (0.61) DRD4DRD2DRD3CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL10513895 0.79 DRD4 (0.64) DRD4DRD2DRD3CYP1A2CYP3A4
SCHEMBL5666675 0.78 DRD4 (0.63) DRD4DRD2DRD3CYP1A2CYP3A4
SCHEMBL8719930 0.77 DRD4 (0.66) DRD4DRD2DRD3CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2239260-A1 Novel compounds with antibacterial activity Morphochem Aktiengesellschaft Für Kombinatorische Chemie (DE) 2010-10-13 EP disclosed
EP-1551829-A2 NOVEL COMPOUNDS WITH ANTIBACTERIAL ACTIVITY Morphochem Aktiengesellschaft Für Kombinatorische Chemie (DE) 2005-07-13 EP disclosed
WO-2004035569-A2 NOVEL COMPOUNDS WITH ANTIBACTERIAL ACTIVITY Morphochem Aktiengesellschaft für kombinatorische Chemie (DE) 2004-04-29 WO disclosed
EP-0559046-B1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors HOFFMANN LA ROCHE (CH) 2001-07-11 EP disclosed
EP-0468231-B1 Guanidins HOFFMANN LA ROCHE (CH) 1994-09-21 EP disclosed
EP-0559046-A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1993-09-08 EP disclosed
EP-0468231-A2 Guanidins F. HOFFMANN-LA ROCHE AG (CH) 1992-01-29 EP disclosed